| Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo J Xu, D Rodriguez, E Petitclerc, JJ Kim, M Hangai, SM Yuen, GE Davis, ... The Journal of cell biology 154 (5), 1069-1080, 2001 | 636 | 2001 |
| New functions for non-collagenous domains of human collagen type IV: Novel integrin ligands inhibiting angiogenesis and tumor growthin vivo E Petitclerc, A Boutaud, A Prestayko, J Xu, Y Sado, Y Ninomiya, ... Journal of Biological Chemistry 275 (11), 8051-8061, 2000 | 388 | 2000 |
| Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis GA McMahon, E Petitclerc, S Stefansson, E Smith, MKK Wong, ... Journal of Biological Chemistry 276 (36), 33964-33968, 2001 | 352 | 2001 |
| Integrin αVβ3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival E Petitclerc, S Strömblad, TL von Schalscha, F Mitjans, J Piulats, ... Cancer research 59 (11), 2724-2730, 1999 | 346 | 1999 |
| Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1 S Stefansson, E Petitclerc, MKK Wong, GA McMahon, PC Brooks, ... Journal of Biological Chemistry 276 (11), 8135-8141, 2001 | 240 | 2001 |
| Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling S Stefansson, GA McMahon, E Petitclerc, DA Lawrence Current pharmaceutical design 9 (19), 1545-1564, 2003 | 209 | 2003 |
| Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces M Crombez, P Chevallier, E Petitclerc, D Mantovani, G Laroche Biomaterials 26 (35), 7402-7409, 2005 | 143 | 2005 |
| Ultra‐small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI L Faucher, AA Guay‐Bégin, J Lagueux, MF Côté, E Petitclerc, MA Fortin Contrast media & molecular imaging 6 (4), 209-218, 2011 | 132 | 2011 |
| Engineering surfaces for bioconjugation: developing strategies and quantifying the extent of the reactions V Gauvreau, P Chevallier, K Vallières, É Petitclerc, RC Gaudreault, ... Bioconjugate chemistry 15 (5), 1146-1156, 2004 | 82 | 2004 |
| Kinin receptors: functional aspects F Marceau, T Sabourin, S Houle, JP Fortin, E Petitclerc, G Molinaro, ... International immunopharmacology 2 (13-14), 1729-1739, 2002 | 81 | 2002 |
| Design, synthesis, biological evaluation, and structure–activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates as new tubulin inhibitors … S Fortin, L Wei, E Moreau, J Lacroix, MF Côté, É Petitclerc, LP Kotra, ... Journal of medicinal chemistry 54 (13), 4559-4580, 2011 | 80 | 2011 |
| Covalent grafting of fibronectin onto plasma‐treated PTFE: Influence of the conjugation strategy on fibronectin biological activity K Vallières, É Petitclerc, G Laroche Macromolecular bioscience 7 (5), 738-745, 2007 | 77 | 2007 |
| Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells. F Potvin, E Petitclerc, F Marceau, PE Poubelle Journal of immunology (Baltimore, Md.: 1950) 158 (4), 1872-1879, 1997 | 75 | 1997 |
| Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site S Fortin, J Lacroix, MF Côté, E Moreau, É Petitclerc, R C-Gaudreault Biological procedures online 12, 113-117, 2010 | 71 | 2010 |
| MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment M Bérubé, A Deschambeault, M Boucher, L Germain, E Petitclerc, ... Mol vis 11 (1101), 11, 2005 | 71 | 2005 |
| Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl) ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion … E Petitclerc, RG Deschesnes, MF Côté, C Marquis, R Janvier, J Lacroix, ... Cancer research 64 (13), 4654-4663, 2004 | 61 | 2004 |
| Optimized N-phenyl-N′-(2-chloroethyl) ureas as potential antineoplastic agents: Synthesis and growth inhibition activity E Moreau, S Fortin, M Desjardins, JLC Rousseau, É Petitclerc, C René Bioorganic & medicinal chemistry 13 (24), 6703-6712, 2005 | 60 | 2005 |
| Synergism between the contractile effect of epidermal growth factor and that of des‐Arg9‐bradykinin or of α.‐thrombin in rabbit aortic rings D deBlois, G Drapeau, E Petitclerc, F Marceau British journal of pharmacology 105 (4), 959-967, 1992 | 59 | 1992 |
| Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings F Rioux, E Petitclerc, R Audet, G Drapeau, RM Fielding, F Marceau Journal of cardiovascular pharmacology 24 (2), 229-237, 1994 | 52 | 1994 |
| Microtubule-destabilizing agents induce focal adhesion structure disorganization and anoikis in cancer cells RG Deschesnes, A Patenaude, JLC Rousseau, JS Fortin, C Ricard, ... Journal of Pharmacology and Experimental Therapeutics 320 (2), 853-864, 2007 | 50 | 2007 |
